Accord Healthcare recalls Rosuvastatin tablets for manufacturing deviations
Accord Healthcare is recalling Rosuvastatin 10 mg tablets due to manufacturing deviations identified during FDA inspection. No illnesses or injuries have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a prescription medication due to manufacturing deviations. This constitutes a risk-of-harm product where injury has not yet been reported, but potential for adverse health consequences exists if deviations affected drug quality, potency, or safety.
Plain-English summary
Accord Healthcare, Inc. is recalling Rosuvastatin 10 mg tablets due to Current Good Manufacturing Practice (CGMP) deviations identified during a U.S. Food and Drug Administration inspection. The recall affects 56,862 bottles distributed across the United States, Puerto Rico, and Canada.
The affected product is packaged in 90-count and 1,000-count bottles. Multiple batch codes are included in this recall, with expiration dates ranging from August 2023 through July 2025.
No illnesses or injuries related to this recall have been reported. Patients currently taking recalled Rosuvastatin should contact their healthcare provider or pharmacist about their treatment options. Do not use the product after the expiration date printed on the bottle.
For questions or to report adverse effects, consumers and healthcare providers should contact Accord Healthcare, Inc. or the FDA.
The recalled product
- Product
- ROSUVASTATIN (ROSUVASTATIN)
- Brand
- ROSUVASTATIN
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batches: a) P2006824
- Exp. Date 11/30/2023
- P2102223
- Exp. Date 3/31/2024
- b) P2004949
- Exp. Date 8/31/2023
- P2004948
- P2004950
- P2004953
- P2004954
- P2004956
- P2004955
- P2004957
- P2004958
- P2004959
- P2005252
- Exp. Date 9/30/2023
- P2006607
- P2101368
- Exp. Date 2/29/2024
UPCs (2)
- 316729285155
- 316729285179
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · ROSUVASTATIN
- ModerateRosuvastatin tablets recalled for manufacturing quality control deviations
FDA (Drugs) · 2023-03-08
- ModerateRosuvastatin Tablets 5mg Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
- HighFDA Recalls Rosuvastatin Tablets Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateFentanyl Citrate Sterile Injection Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27